These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31085640)

  • 1. In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.
    Davis MT; Hillmer A; Holmes SE; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Angarita GA; Carson RE; Krystal JH; Esterlis I
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11490-11495. PubMed ID: 31085640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study.
    Leurquin-Sterk G; Van den Stock J; Crunelle CL; de Laat B; Weerasekera A; Himmelreich U; Bormans G; Van Laere K
    J Nucl Med; 2016 Nov; 57(11):1746-1752. PubMed ID: 27283933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.
    Holmes SE; Girgenti MJ; Davis MT; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Southwick S; Duman RS; Carson RE; Krystal JH; Esterlis I;
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8390-8395. PubMed ID: 28716937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals With Major Depressive and Posttraumatic Stress Disorders.
    Baldassarri SR; Asch RH; Hillmer AT; Pietrzak RH; DellaGioia N; Esterlis I; Davis MT
    Chronic Stress (Thousand Oaks); 2023; 7():24705470231154842. PubMed ID: 36843572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
    Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.
    Abdallah CG; Hannestad J; Mason GF; Holmes SE; DellaGioia N; Sanacora G; Jiang L; Matuskey D; Satodiya R; Gasparini F; Lin X; Javitch J; Planeta B; Nabulsi N; Carson RE; Esterlis I
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jul; 2(5):449-456. PubMed ID: 28993818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [
    Mecca AP; Rogers K; Jacobs Z; McDonald JW; Michalak HR; DellaGioia N; Zhao W; Hillmer AT; Nabulsi N; Lim K; Ropchan J; Huang Y; Matuskey D; Esterlis I; Carson RE; van Dyck CH
    Neuroimage; 2021 Sep; 238():118217. PubMed ID: 34052464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Role of mGluR5 in Cognitive Processes in Posttraumatic Stress Disorder and Major Depression.
    Esterlis I; DeBonee S; Cool R; Holmes S; Baldassari SR; Maruff P; Pietrzak RH; Davis MT
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221105804. PubMed ID: 35958037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the effects of ketamine on mGluR5 using [
    Holmes SE; Gallezot JD; Davis MT; DellaGioia N; Matuskey D; Nabulsi N; Krystal JH; Javitch JA; DeLorenzo C; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2254-2264. PubMed ID: 31744389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients.
    Ceccarini J; Leurquin-Sterk G; Crunelle CL; de Laat B; Bormans G; Peuskens H; Van Laere K
    J Nucl Med; 2020 Feb; 61(2):256-262. PubMed ID: 31481578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [
    Esterlis I; DellaGioia N; Pietrzak RH; Matuskey D; Nabulsi N; Abdallah CG; Yang J; Pittenger C; Sanacora G; Krystal JH; Parsey RV; Carson RE; DeLorenzo C
    Mol Psychiatry; 2018 Apr; 23(4):824-832. PubMed ID: 28397841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.
    Sullivan GM; Oquendo MA; Milak M; Miller JM; Burke A; Ogden RT; Parsey RV; Mann JJ
    JAMA Psychiatry; 2015 Feb; 72(2):169-78. PubMed ID: 25549105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two PET radioligands, [
    Lohith TG; Tsujikawa T; Siméon FG; Veronese M; Zoghbi SS; Lyoo CH; Kimura Y; Morse CL; Pike VW; Fujita M; Innis RB
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2458-2470. PubMed ID: 27629098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of mGluR5 in Alzheimer's disease.
    Mecca AP; McDonald JW; Michalak HR; Godek TA; Harris JE; Pugh EA; Kemp EC; Chen MK; Salardini A; Nabulsi NB; Lim K; Huang Y; Carson RE; Strittmatter SM; van Dyck CH
    Alzheimers Res Ther; 2020 Jan; 12(1):15. PubMed ID: 31954399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.
    Esterlis I; Holmes SE; Sharma P; Krystal JH; DeLorenzo C
    Biol Psychiatry; 2018 Jul; 84(2):95-105. PubMed ID: 29100629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
    DeLorenzo C; Sovago J; Gardus J; Xu J; Yang J; Behrje R; Kumar JS; Devanand DP; Pelton GH; Mathis CA; Mason NS; Gomez-Mancilla B; Aizenstein H; Mann JJ; Parsey RV
    Transl Psychiatry; 2015 Dec; 5(12):e693. PubMed ID: 26645628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study.
    Brašić JR; Nandi A; Russell DS; Jennings D; Barret O; Martin SD; Slifer K; Sedlak T; Seibyl JP; Wong DF; Budimirovic DB
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans.
    Hulka LM; Treyer V; Scheidegger M; Preller KH; Vonmoos M; Baumgartner MR; Johayem A; Ametamey SM; Buck A; Seifritz E; Quednow BB
    Mol Psychiatry; 2014 May; 19(5):625-32. PubMed ID: 23628984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.